Course Provider
Learning Objectives
Participants will discuss current options for treatment of metastatic castration-sensitive prostate cancer, including triplet therapy with androgen deprivation therapy, chemotherapy, and novel hormone therapy.
Participants will describe treatment options and how they are selected for patients with metastatic castration-resistant prostate cancer.
Participants will identify common supportive care needs and approaches for patients with metastatic prostate cancer.